1. Home
  2. PLNT vs ABVX Comparison

PLNT vs ABVX Comparison

Compare PLNT & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Fitness Inc.

PLNT

Planet Fitness Inc.

HOLD

Current Price

$105.85

Market Cap

9.1B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$114.15

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLNT
ABVX
Founded
1992
2013
Country
United States
France
Employees
N/A
N/A
Industry
Hotels/Resorts
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
9.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
PLNT
ABVX
Price
$105.85
$114.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
12
Target Price
$118.42
$118.33
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
02-24-2026
08-11-2025
Dividend Yield
N/A
N/A
EPS Growth
31.23
N/A
EPS
2.44
N/A
Revenue
$1,202,700,000.00
$6,231,374.00
Revenue This Year
$21.43
$6.80
Revenue Next Year
$11.05
N/A
P/E Ratio
$42.77
N/A
Revenue Growth
14.63
N/A
52 Week Low
$87.72
$4.77
52 Week High
$114.47
$148.83

Technical Indicators

Market Signals
Indicator
PLNT
ABVX
Relative Strength Index (RSI) 43.99 43.25
Support Level $103.49 $116.20
Resistance Level $110.53 $129.56
Average True Range (ATR) 2.44 7.87
MACD -0.84 -2.47
Stochastic Oscillator 36.59 15.05

Price Performance

Historical Comparison
PLNT
ABVX

About PLNT Planet Fitness Inc.

Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: